Myocardial metabolic changes during pediatric cardiac surgery: A randomized study of 3 cardioplegic techniques  by Modi, P. et al.
Modi et al Surgery for Congenital Heart DiseaseMyocardial metabolic changes during pediatric cardiac





A. J. Parry, FRCS




See related editorial on page 11.
From Bristol Heart Institute, University of
Bristol, Bristol Royal Infirmary, Bristol,
United Kingdom.
Supported by the British Heart Foundation,
National Heart Research Fund, and Garfield
Weston Trust.
Received for publication June 23, 2003;
revisions received Oct 11, 2003; accepted
for publication Nov 5, 2003.
Address for reprints: M.-S. Suleiman, PhD,
Bristol Heart Institute, University of Bris-
tol, Bristol Royal Infirmary, Bristol BS2
8HW, United Kingdom (E-mail:
M.S.Suleiman@bris.ac.uk).
J Thorac Cardiovasc Surg 2004;128:67-75
0022-5223/$30.00
Copyright © 2004 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2003.11.071Background: Blood cardioplegia and terminal warm blood cardioplegic reperfusion
(“hot shot”) reduce myocardial injury and improve metabolic recovery in hypoxic
but not normoxic experimental models. However, there is little evidence of a benefit of
either technique in pediatric clinical practice compared with crystalloid cardioplegia.
Methods: Pediatric patients undergoing cardiac surgery were randomized to receive
intermittent antegrade cold crystalloid cardioplegia, cold blood cardioplegia, or cold
blood cardioplegia with a hot shot. Right ventricular biopsy specimens were
collected before ischemia, at the end of ischemia, and 20 minutes after reperfusion.
Cellular metabolites were analyzed. In acyanotic patients postoperative serum
troponin I levels were also measured at 1, 4, 12, 24, and 48 hours.
Results: Of 103 patients recruited, 32 (22 acyanotic and 10 cyanotic), 36 (24
acyanotic and 12 cyanotic), and 35 (25 acyanotic and 10 cyanotic), respectively,
were allocated to the groups receiving cold crystalloid cardioplegia, cold blood
cardioplegia, and cold blood cardioplegia with a hot shot. Cyanotic patients were
younger, with longer crossclamp times. There were no significant differences in
clinical outcomes between cardioplegic methods. The cardioplegic method had no
overall effect in terms of adenosine triphosphate, ln(adenosine triphosphate/adeno-
sine diphosphate), or ln(glutamate) in acyanotic patients (P  .11, P  .66, and P
 .30, respectively). Also, there was no significant difference between groups in
troponin I release. However, in cyanotic patients cold blood cardioplegia with a hot
shot significantly reduced the decrease in adenosine triphosphate, ln(adenosine
triphosphate/adenosine diphosphate), and glutamate observed at the end of ischemia
and after reperfusion compared with the decrease seen in those receiving cold
crystalloid cardioplegia (P .002, P .003, and P .008, respectively), with cold
blood cardioplegia representing an intermediate.
Conclusions: For cyanotic patients (younger, with longer crossclamp times), cold
blood cardioplegia with a hot shot is the best method of myocardial protection. For
acyanotic patients (older, with shorter crossclamp times), cardioplegic technique is
not critical.
Low cardiac output after surgically induced ischemia and reperfusioncontinues to be a major contributor to morbidity and mortality afterpediatric cardiac surgery and, in more than 50% of cases, has beenattributed to inadequate myocardial protection.1,2 We have recentlydemonstrated that cold crystalloid cardioplegia is associated withsignificant ischemic stress and myocardial injury and that the extent
3of this is dependent on the presence of cyanosis. In adults blood cardioplegia has
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Dbeen shown to be superior to crystalloid cardioplegia, but
because of the structural, functional, and biochemical dif-
ferences between mature and immature myocardium, adult
cardioprotective strategies should not be extrapolated un-
critically to pediatric practice.4,5 By using a clinically rele-
vant in vivo piglet model, blood cardioplegia has been
shown to be superior to crystalloid cardioplegia in acutely
hypoxic hearts, whereas both methods of cardioplegia pro-
vide protection in hearts not compromised by preoperative
hypoxia.6 However, crystalloid cardioplegia, with its ease of
use and less interference with visibility, is still widely
used.7,8
Postischemic recovery of function can be further opti-
mized through careful control of the conditions of reperfu-
sion and the composition of the reperfusate.9,10 A terminal
warm blood cardioplegic reperfusate or “hot shot” allows
cellular energy stores to be regenerated and channeled into
repairing reversibly injured myocardium during a period of
electromechanical quiescence.11,12 It has been shown exper-
imentally to improve metabolic and short-term functional
recovery and to decrease mortality in adult cardiac opera-
tions.13,14 In the immature heart this technique has been
demonstrated to be effective in hypoxic piglet hearts15 and
after prolonged ischemia (2 hours) in normoxic neonatal
lamb hearts.16 However, this technique is rarely used in
pediatric practice.
The aim of this study was to compare the effects of cold
crystalloid cardioplegia (CC), cold blood cardioplegia (CB),
and CB with terminal warm blood cardioplegic reperfusion
(“hot shot”; CBHS) on the intracellular concentrations of
biochemical markers of ischemic stress in both cyanotic and
acyanotic pediatric patients undergoing cardiac surgery.
The postoperative release of troponin I (TnI), a sensitive
marker of myocardial injury, and several clinical outcomes
were also measured.
Materials and Methods
Pediatric patients undergoing elective repair of congenital heart
defects between June 2000 and December 2001 at the Royal
Hospital for Children, Bristol, were prospectively randomized to
receive either intermittent antegrade CC (St Thomas I crystalloid
cardioplegia, 20 mmol/L KCl, 16 mmol/L MgCl2, 2.2 mmol/L
CaCl2, 144 mmol/L NaCl, and 1.0 mmol/L procaine HCl), CB (4:1
dilution blood/St Thomas’ I crystalloid cardioplegia to give the
same at-patient concentrations), or CBHS.
Simple random treatment allocations (ie, not blocked or strat-
ified) were generated in advance of starting the study and were
concealed in sequentially numbered and sealed opaque envelopes.
After written informed parental consent was obtained, a patient
was randomized by opening the next numbered envelope. The
study was approved by the hospital ethics committee.
Anesthetic and Surgical Technique
Anesthetic technique was standardized, as reported previously.3
Cardiopulmonary bypass (CPB) was established between ascend-
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mia (28°C-32°C). After the aorta was crossclamped, either CC or
CB was infused into the aortic root at 4°C. The induction dose was
110 mL · m2 · min1 antegradely for 4 minutes, with a mainte-
nance dose of 110 mL · m2 · min1 for 2 minutes at 20- to
30-minute intervals. Aortic root pressure was measured in every
patient during cardioplegic delivery and was maintained between
40 and 50 mm Hg. Topical cooling with cold saline solution
(4°C-6°C) was used in all patients. The hot shot was identical in
composition to the induction and maintenance doses and was
administered at 110 mL · m2 · min1 for 2 minutes at 37°C
immediately before unclamping the aorta.
Postoperative Management and Assessment of Clinical
Outcome
All patients were admitted to the pediatric intensive care unit
(ICU) after the operation and managed by intensivists and pediat-
ric cardiologists. Decisions regarding inotropic support and venti-
lation were based on unit protocols, hemodynamic status (eg, low
mixed venous saturation and high lactic acidosis), and clinical
judgment.3 Intraoperative and postoperative clinical parameters
were measured. These included the durations of CPB, aortic cross-
clamping time, inotropic support, ventilation, ICU stay, and hos-
pital stay.
Collection of Ventricular Biopsy Specimens
Myocardial biopsy specimens (mean weight  SD, 3.6  2.2 mg)
were collected from the anterior wall of the right ventricle by using
an 18-gauge, 6–cm Trucut biopsy needle (Allegiance Healthcare)
immediately before crossclamping the aorta (control biopsy), just
before releasing the crossclamp (ischemic biopsy), and after 20
minutes of reperfusion (reperfusion biopsy). Each specimen was
immediately frozen in liquid nitrogen until processing for the
analysis of adenine nucleotides, purines, lactate, and glutamate, as
previously reported.3,14
Measurement of Cardiac TnI
Serum concentrations of TnI were determined before surgical
intervention and at 1, 4, 12, 24, and 48 hours postoperatively by
using the ACCESS Immunoassay System (Beckman Instruments).
The total TnI release was calculated by using the area under the
curve. Because the majority of cyanotic patients require some form
of myocardial resection (to relieve obstruction of the right ven-
tricular outflow tract) and because this is known to influence TnI
release, TnI levels were only measured in acyanotic patients.3,17,18
Data Collection and Statistical Analysis
Descriptive data are summarized in tables by using medians and
interquartile ranges. Clinical outcomes were compared by using 2
tests and Kruskal-Wallis 1-way nonparametric analysis of variance
(ANOVA). Metabolic and TnI data are presented graphically as
means  95% confidence intervals. The effects of cardioplegic
method, cyanosis, time (ie, control, ischemia, and reperfusion),
and the interactions of these factors were investigated by means of
repeated-measures ANOVA. A natural logarithmic transformation
was applied to the data for all variables except adenosine triphos-
phate (ATP) to normalize their distributions. The baseline level
(obtained from the first biopsy specimen) was entered into the
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DANOVA as a covariate, and ischemic and reperfusion biopsy
specimens were investigated as repeated measures. The 3-way
interaction of cardioplegic group, cyanosis, and time was often
significant in the overall ANOVA, making the findings difficult to
interpret. Separate ANOVAs for acyanotic and cyanotic subgroups
were subsequently carried out to help interpretation. All data were
analyzed with STATA version 7.0 software (STATA Corp).
Results
A total of 103 children were recruited into the study: 71
acyanotic and 32 cyanotic children. Twenty-two, 24, and 25
acyanotic children were randomly allocated to CC, CB, and
CBHS cardioplegia, respectively; 10, 12, and 10 cyanotic
children were randomly allocated to the corresponding
groups. The characteristics of the patients and intraoperative
variables are summarized in Table 1, and the diagnoses are
summarized in Table 2. Cyanotic patients tended to be
younger and had longer CPB and aortic crossclamp times.
Clinical Outcomes
There were 2 postoperative deaths, both in the CB cardio-
plegia group: one, a 6-month-old acyanotic infant with a
complete atrioventricular canal and left and right ventricular
outflow tract obstruction, died 13 days postoperatively after
a period of extracorporeal support; the other, a 21-month-
old cyanotic child with pulmonary atresia, died on the first
postoperative night after unsuccessful resuscitation from a
cardiac arrest. In both cases postmortem examination re-
vealed no evidence of myocardial infarction but was other-
wise unhelpful in establishing a cause of death.
There were no significant differences in the durations or
amounts of inotropic support required (P  .57 and P 
.80), duration of ventilation (P  .95), ICU (P  .90), or
hospital stay (P  .87) between the cardioplegic groups
(Table 3). Cyanotic patients needed significantly more post-
operative inotropic and ventilatory support than acyanotic







Age (mo) 43 (4.5-69.0) 41 (9-98)
Sex (M/F) 9/13 16/8
Body weight (kg) 14.5 (5.3-20.4) 12.8 (7.6-24.3
Preoperative hemoglobin (g/dL) 12.5 (11.4-13.9) 12.6 (12.0-13
Intraoperative variables
CPB time (min) 67 (46-93) 71 (49-86)
ACC time (min) 40 (27-56) 40 (31-56)
CPB temperature (°C) 32 (28-32) 32 (28-32)
Medians and interquartile ranges are shown for continuous variables.
CC, Cold crystalloid cardioplegia; CB, cold blood cardioplegia; CBHS, c
crossclamp.patients and spent longer in the ICU and in the hospital.
The Journal of ThoracMetabolic Changes During Ischemia and Reperfusion
ATP. In the overall analysis of ATP levels, the main
effect of the cardioplegic group was not significant in the
3-way ANOVA (P  .08), although the 3-way interaction
of cardioplegic group, cyanosis, and time was significant (P
 .02; time is control, ischemia, or reperfusion). Separate
ANOVAs for acyanotic and cyanotic patients showed
clearly that the effect of cardioplegic method was different
in these subgroups. Cardioplegic method appeared to have
no overall effect in acyanotic patients (P  .11) but had a
significant overall effect in cyanotic patients (P  .002).
This latter finding was also complicated by an interaction
between cardioplegic technique and time (P  .02). These
findings are illustrated in Figure 1, which shows that there
is a clear and parallel decrease in ATP, both during ischemia








Acyanotic ASD 6 6 6
VSD 13 12 15










Cyanotic Tetralogy of Fallot 8 9 9
Pulmonary atresia 2 2 1
DILV 0 1 0
CC, Cold crystalloid cardioplegia; CB, cold blood cardioplegia; CB  HS,
cold blood cardioplegia  hot shot; ASD, atrial septal defect; VSD, ven-











29 (6-86) 13 (10-23) 9 (7-16) 14 (10-16)
14/11 8/2 5/7 5/5
10.9 (6.5-19.1) 9.7 (8.9-10.5) 7.8 (6.3-10.0) 8.8 (7.0-9.2)
11.9 (11.3-12.8) 15.0 (13.2-15.8) 15.0 (14.6-16.4) 14.0 (12.7-16.3)
74 (46-86) 110 (63-141) 145 (125-155) 133 (97-149)
41 (31-54) 59 (28-78) 74 (43-83) 71 (31-87)
32 (28-32) 28 28 28
ood cardioplegia  hot shot; CPB, cardiopulmonary bypass; ACC, aorticles
)
.7)
old blcyanotic groups, except for the cyanotic patients who re-
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Dceived CBHS cardioplegia. If anything, in this latter sub-
group the level of ATP after 20 minutes of reperfusion
appeared to increase.
ATP/adenosine diphosphate ratio. The findings for the






First sustained rhythm on reperfusion
SR 16 16
Nodal or 1°/2° block 5 6
CHB 1 0
Inotropic duration (h) 20 (8-25) 23 (14-30)
Total g dopamine/kg (103) 5.9 (1.2-9.5) 5.1 (1.9-7.0
Ventilation (h) 14 (4-24) 13 (4-30)
ICU stay (h) 42 (26-48) 44 (24-52)
Hospital stay (d) 7 (6-9) 7 (5-9)
Medians and interquartile ranges are shown for continuous variables.
CC, Cold crystalloid cardioplegia; CB, cold blood cardioplegia; CB  HS, co
CHB, complete heart block; ICU, intensive care unit.
Figure 1. Bar chart showing ATP and ln(ATP/ADP) be
reperfusion in acyanotic and cyanotic patients by us
means  95% confidence intervals. CC, Cold crystalloATP/adenosine diphosphate (ADP) ratio were very similar
70 The Journal of Thoracic and Cardiovascular Surgery ● July 2to those for ATP (Figure 2). Again, cyanotic patients who
received CBHS appear to have benefited selectively (main
effect of cardioplegic technique, P  .003; interaction of










12 7 9 3
8 2 1 6
2 1 0 1
27 (20-41) 52 (48-99) 55 (44-138) 62 (44-123)
7.2 (5.4-8.7) 17.1 (14.0-26.7) 16.0 (12.2-36.1) 16.7 (10.5-25.6)
20 (6-23) 48 (26-96) 42 (25-95) 44 (29-135)
44 (28-50) 130 (102-216) 104 (72-161) 96 (72-159)
7 (6-8) 12 (10-16) 11 (9-12) 9 (7-12)
od cardioplegia with terminal warm blood cardioplegia; SR, sinus rhythm;
and at the end of ischemia and after 20 minutes of
he 3 cardioplegic techniques. Data are presented as
B, cold blood; CBHS, cold blood plus hot shot.)
ld blofore
ing t
id; Ceffect of cardioplegic technique (P  .66), nor was there an
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among acyanotic patients. Although the interaction between
cardioplegic technique and time for cyanotic patients was
not statistically significant, Figure 2 shows a very similar
pattern to Figure 1, with the decrease in the ATP/ADP ratio
after 20 minutes of reperfusion shown by all other groups not
being apparent in the cyanotic patients who received a hot shot.
Other ATP metabolites. Similar analyses were carried
out for ADP, adenosine monophosphate, inosine, adenosine,
and hypoxanthine. There were no significant differences
among the cardioplegic groups for any of these metabolites
in acyanotic or cyanotic patients. The findings for these
metabolites are not described in detail here because their
levels either duplicate the findings presented (eg, ADP) or
represent intermediate steps in metabolism of ATP. How-
ever, ATP byproducts (eg, inosine) showed the expected
pattern of accumulation during ischemia and subsequent
decrease during reperfusion, with no interactions with car-
dioplegic technique. P values for the main effects of time
for inosine were .02 and .0001 for the acyanotic and cya-
notic groups, respectively (Table 4).
Glutamate. The findings for glutamate levels are also
very similar to those for ln(ATP/ADP) and ATP (Figure 2).
The cyanotic patients who received CBHS appear not to
have experienced the continuing decrease in glutamate after
20 minutes of reperfusion that was observed in all other
groups. In the separate analyses only the main effect of time
was significant among acyanotic patients (P  .0001), with
no difference among the cardioplegic techniques. However,
among cyanotic patients, the main effect of cardioplegic
technique and the interaction of cardioplegic technique with
time were both statistically significant (P  .008 and P 
.003, respectively). Glutamate continued to decrease on
reperfusion in the CC group but increased in the CBHS
group after a hot shot. The CB group of cyanotic patients
appeared to represent an intermediate result between that for
the CC and CBHS groups.
Lactate. The findings for lactate levels differ from those
described above for ATP, ln(ATP/ADP), and glutamate (Fig-
ure 3). In the overall analysis the 3-way interaction was not
significant (P .80), but in separate analyses the interaction of
cardioplegic method and time approached significance for the
acyanotic group (P .06), although not for the cyanotic group
(P .21). The effect of time was significant for both acyanotic
and cyanotic patients (P  .03 and P  .0003, respectively).
Figure 4 shows that the atypical group in this case were the
acyanotic patients who received CC cardioplegia; they did not
show the decrease in lactate after 20 minutes of reperfusion
that was observed for all other groups.
TnI release
In acyanotic patients TnI release was significantly increased
by 1 hour postoperatively, peaked at 4 hours, and thereafter
The Journal of Thoracdecreased (Figure 4). However, after 48 hours, TnI levels
were still increased to greater than baseline levels (data not
shown on the graph because there were several missing
values as a result of a lack of intravenous access). Figure 4
shows that TnI levels were higher at each time point in
acyanotic patients who received CBHS cardioplegia.
These apparent differences were investigated by means of a
repeated-measures ANOVA of the logged TnI data, which
showed that neither the overall effect of cardioplegic
method nor the interaction of cardioplegic method and time
reached statistical significance (P  .13 and P  .12,
respectively).
Discussion
This study demonstrates that the effects of the 3 methods of
Figure 2. Bar chart showing ln(glutamate) before and at the end
of ischemia and after 20 minutes of reperfusion in acyanotic and
cyanotic patients by using the 3 cardioplegic techniques. Data
are presented as means  95% confidence intervals. CC, Cold
crystalloid; CB, cold blood; CBHS, cold blood plus hot shot.cardioplegia differ in the 2 groups of pediatric patients:
ic and Cardiovascular Surgery ● Volume 128, Number 1 71
Surgery for Congenital Heart Disease Modi et al
CH
Dacyanotic (who tend to be older, with shorter crossclamp
times) and cyanotic (younger, with longer crossclamp
times). CBHS is the best method in cyanotic patients; CB
on its own appears to be better than CC but not as good as
CBHS. In acyanotic patients the method of cardioplegia
appears not to be critical in the setting of relatively brief
crossclamp time (45 minutes).
Limitations of the Study
In reporting the results, we have focused on the analyses
carried out separately for acyanotic and cyanotic patients
rather than the overall results, despite the fact that this
subgroup analysis was not written into the protocol. How-
ever, the subgroup analysis was planned soon after recruit-
ment and started when it became evident that the groups of
acyanotic and cyanotic children differed so markedly with
respect to their clinical characteristics and metabolic recov-
ery. Therefore the subgroup analysis should be considered
to be a priori rather than post hoc. There was no evidence of
imbalance in preoperative characteristics on the basis of the
TABLE 4. Means (ATP)/geometric means* (all other metabo









Baseline 41.7 (36.7-46.8) 39.5 (33.7-45.2) 36.3 (
Ischemia 36.0 (30.5-41.5) 31.5 (27.2-35.9) 29.4 (
Reperfusion 25.8 (21.0-30.5) 24.7 (19.8-29.5) 18.8 (
ADP
Baseline 14.6 (12.3-17.4) 14.8 (12.9-17.0) 14.8 (
Ischemia 15.6 (13.3-18.2) 16.1 (14.3-18.1) 14.5 (
Reperfusion 15.5 (13.2-18.3) 14.9 (12.9-17.2) 13.4 (
AMP
Baseline 2.34 (1.74-3.16) 3.06 (2.33-4.03) 3.21 (
Ischemia 3.31 (2.82-3.89) 3.86 (3.26-4.58) 3.37 (
Reperfusion 4.32 (3.50-5.34) 4.40 (3.56-5.43) 4.36 (
Inosine
Baseline 0.95 (0.69-1.30) 1.03 (0.76-1.39) 0.94 (
Ischemia 1.69 (1.27-2.23) 2.18 (1.55-3.07) 2.23 (
Reperfusion 1.66 (1.28-2.16) 1.68 (1.25-2.26) 1.72 (
Adenosine
Baseline 0.35 (0.26-0.47) 0.41 (0.30-0.56) 0.45 (
Ischemia 0.49 (0.40-0.61) 0.61 (0.47-0.80) 0.66 (
Reperfusion 0.52 (0.40-0.67) 0.61 (0.47-0.81) 0.58 (
Hypoxanthine
Baseline 0.19 (0.15-0.25) 0.24 (0.18-0.33) 0.27 (
Ischemia 0.55 (0.45-0.68) 0.59 (0.42-0.83) 0.71 (
Reperfusion 0.63 (0.47-0.85) 0.51 (0.40-0.64) 0.57 (
CC, Cold crystalloid cardioplegia; CB, cold blood cardioplegia; CB  HS, c
triphosphate; ADP, adenosine diphosphate; AMP, adenosine monophosph
*All values are in natural units (ie, nmol/mg protein). However, geometr
exp[mean of logged values  1.96 SEs]) are reported for all metabolites o
skewed.method of cardioplegia within the acyanotic and cyanotic
72 The Journal of Thoracic and Cardiovascular Surgery ● July 2subgroups. Therefore it is extremely unlikely that the dif-
ferences in the pattern of results between methods of car-
dioplegia with the acyanotic and cyanotic subgroups can be
explained by confounding factors.
Age, Ischemic Duration, and Pathology
The small sample size of the cyanotic group limits the
power of the study for this subgroup. It also prevented an
analysis of a differential effect of cardioplegic technique by
age (ie, 12 months vs 12 months), although because
cyanotic patients are generally younger, the independent
contribution of an effect of age is perhaps academic. The
ischemic duration was also significantly longer in the cya-
notic group: in a randomized trial it is not possible to control
this because it reflects the greater surgical complexity of this
group of children. Cyanosis and crossclamp time are inex-
tricably linked, and therefore any independent effect of
clamp time is perhaps academic. However, if a subgroup
analysis is performed of those cyanotic patients with the
shortest crossclamp times, CBHS is still better than CB,










39.5) 45.9 (40.1-51.8) 34.6 (26.5-42.7) 41.4 (34.6-48.3)
31.7) 24.4 (15.8-33.1) 23.8 (15.6-32.0) 29.9 (23.1-36.8)
22.0) 12.5 (6.09-18.9) 18.7 (12.8-24.5) 34.8 (31.7-38.0)
16.9) 17.1 (12.9-22.8) 13.8 (11.7-16.4) 15.0 (12.9-17.5)
15.8) 16.1 (13.2-19.7) 12.3 (10.3-14.6) 13.4 (11.5-15.7)
15.4) 10.4 (8.31-13.0) 14.1 (12.1-16.3) 15.8 (13.3-18.9)
4.01) 3.08 (1.88-5.06) 2.99 (2.24-3.98) 2.77 (1.78-4.32)
3.98) 4.69 (2.41-9.14) 3.11 (2.17-4.44) 3.21 (2.06-5.01)
5.23) 3.35 (2.44-4.60) 4.21 (3.33-5.32) 3.28 (2.34-4.59)
1.18) 1.04 (0.70-1.54) 1.44 (1.08-1.91) 1.10 (0.72-1.66)
2.93) 4.50 (2.40-8.41) 4.31 (2.74-6.76) 3.12 (2.06-4.74)
2.15) 1.98 (1.48-2.65) 1.91 (1.39-2.62) 1.54 (0.93-2.57)
0.59) 0.63 (0.42-0.94) 0.65 (0.51-0.83) 0.66 (0.46-0.96)
0.81) 1.32 (0.83-2.09) 0.83 (0.57-1.21) 0.87 (0.60-1.26)
0.73) 1.02 (0.65-1.61) 0.69 (0.56-0.84) 0.57 (0.33-0.96)
0.36) 0.26 (0.18-0.39) 0.36 (0.26-0.50) 0.33 (0.20-0.54)
0.94) 0.83 (0.51-1.35) 1.01 (0.66-1.55) 0.77 (0.47-1.28)
0.73) 0.30 (0.19-0.48) 0.49 (0.35-0.70) 0.67 (0.43-1.02)
lood cardioplegia with terminal warm blood cardioplegia; ATP, adenosine
ans (ie, exp[mean of logged values]) and 95% confidence intervals (ie,
























therwhich is better than CC (data not shown). Almost all cya-
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Dnotic patients and a single pathology, tetralogy of Fallot,
and therefore this is unlikely to have been a confounding
factor.
Interpretation of Study Findings
We have recently shown that the use of CC in pediatric
cardiac surgery is associated with significant ischemic stress
and myocardial injury that is dependent on cyanosis.3 This
study shows that in acyanotic patients there is little im-
provement in terms of metabolic data or clinical outcome if
CB is used. In agreement with this, Fujiwara and col-
leagues19 found no beneficial effect of CB compared with
CC in the normal neonatal lamb heart, although Corno and
associates20 demonstrated improved recovery in the neona-
tal piglet heart. However, in a randomized controlled trial of
21
Figure 3. Bar chart showing ln(lactate) before and at the end of
ischemia and after 20 minutes of reperfusion in acyanotic and
cyanotic patients by using the 3 cardioplegic techniques. Data
are presented as means  95% confidence intervals. CC, Cold
crystalloid; CB, cold blood; CBHS, cold blood plus hot shot.138 pediatric patients, Young and coworkers found no
The Journal of Thoracdifferences in clinical outcome between CC and CB. We
also could not demonstrate any difference between CB and
CC in terms of clinical outcome in a randomized controlled
trial of patients undergoing repair of ventricular septal de-
fects; however, there was less metabolic derangement with
CB.22 It might be that a difference between blood and
crystalloid cardioplegia would have become apparent if the
ischemic (crossclamp) duration had been longer.
Despite the prevalence of hypoxia in the neonatal pop-
ulation, few studies have examined the question of blood
versus crystalloid cardioplegia in the clinical setting. These
hearts will undergo an unintended reoxygenation injury on
commencement of CPB that might alter their tolerance to a
subsequent period of ischemia.23 In this study we have
demonstrated that preoperative cyanosis profoundly affects
the protection of cardioplegic solutions on the myocardium.
Blood cardioplegia partially protected the hypoxic hearts
from ischemic and reoxygenation injury, whereas a severe
cellular injury occurred in those protected with crystalloid
cardioplegia, with a 73% reduction in preischemic mean
ATP levels and a 67% reduction in the mean ATP/ADP
ratio. These results, demonstrating an increased sensitivity
to crystalloid cardioplegia in hypoxic hearts, parallel those
obtained in acutely and chronically hypoxic experimental
models6,24,25 and in infants undergoing tetralogy repair in
whom ATP levels are significantly decreased and lactate
levels persistently increased during reperfusion.25,26 These
findings show that crystalloid cardioplegia provides inade-
quate myocardial protection for hypoxic hearts.
The observation that ATP levels and the ATP/ADP ratio
can be further preserved if electromechanical arrest is main-
tained during the first few minutes of reperfusion in the
Figure 4. Bar chart showing the time-dependent release of TnI in
acyanotic patients. Data are presented as means  95% confi-
dence intervals.stressed (hypoxic) immature heart by means of exposure to
ic and Cardiovascular Surgery ● Volume 128, Number 1 73
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Da hot shot is in agreement with previous laboratory studies
in neonatal piglets.6,15 However, preservation of endoge-
nous glutamate has not been previously demonstrated.
Amino acid use by transamination and substrate level phos-
phorylation increases the resistance of the immature heart to
ischemic damage and improves functional recovery.27 De-
spite the metabolic advantages of warm cardioplegic reper-
fusion, there were no differences in clinical outcomes, in-
dicating that the changes seen during ischemia were
completely reversible. Because ATP has been shown to
correlate with function, it might be that CB and terminal
warm blood cardioplegic reperfusion incrementally amelio-
rate the myocardial stunning associated with crystalloid
cardioplegia.28
Only 2 previous laboratory studies have investigated
warm cardioplegic reperfusion in the immature heart.15,16
Kronon and colleagues15 assessed functional and metabolic
outcomes in stressed neonatal piglet hearts undergoing 60
minutes of ventilator hypoxia before 70 minutes of multid-
ose CB arrest with and without a warm cardioplegic reper-
fusate. This ischemic time is comparable with that seen in
our cyanotic group. They demonstrated a slight improve-
ment in function, assessed by using pressure-volume loops,
with a warm unsupplemented cardioplegic reperfusate. Af-
ter 60 minutes of reperfusion, they showed an increased
ATP and ATP/ADP ratio in the group receiving the car-
dioplegic reperfusate compared with that seen in those
receiving an unmodified blood reperfusate, as we have seen.
However, if aspartate and glutamate were included in the
warm reperfusate, there was almost complete recovery of
function and preservation of ATP. Aspartate and glutamate
are thought to restore depleted Krebs cycle intermediates,
which allows intact mitochondria to produce greater
amounts of ATP through aerobic metabolism.29 In our study
glutamate was found to be reduced to less than baseline
levels, even after reperfusion, in all groups, which might
suggest that glutamate enrichment, aspartate enrichment, or
both of the hot shot would have improved metabolic recov-
ery.
Cyanotic patients receiving a hot shot had higher reper-
fusion ATP, ATP/ADP, and glutamate levels than acyanotic
patients, implying that the hot shot is advantageous only in
stressed hearts (cyanotic and younger with a long ischemic
interval). We do not believe that this implies that acyanotic
patients are more sensitive to ischemia because this group
did not have a greater decrease in metabolites during isch-
emia, and this also does not agree with our previous work.3
Our method of terminal cardioplegia (eg, composition and
duration) might have been suboptimal, such that the benefits
of electromechanical quiescence were only revealed in
those hearts most likely to benefit. In contrast, Nomura and
coworkers16 have reported a functional and metabolic ad-
vantage of warm blood cardioplegic reperfusion in nor-
74 The Journal of Thoracic and Cardiovascular Surgery ● July 2moxic neonatal lamb hearts. The reasons for these differ-
ences are due to the fact that their hearts were more stressed
as a result of triple the duration of global ischemia (120
minutes), the existence of species differences in the re-
sponse to ischemia and cardioplegia,30 a different age group
(ie, level of maturity), and the method of terminal cardio-
plegia.
In summary, for cyanotic patients (who tend to be
younger, with longer crossclamp times), CB supplemented
with a hot shot reduces metabolic injury compared with cold
crystalloid cardioplegia; CB on its own is better than CC but
not as good as CBHS. For acyanotic patients (older, with
shorter crossclamp times), the method of cardioplegia is not
critical when the crossclamp time is less than 45 minutes.
We thank Mark Ginty and Svitlana Korolchuk for performing
the biochemical analyses, Mr D. Trivedi, and the pediatric nursing
staff for their support.
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